Edward White
Stock Analyst at HC Wainwright & Co.
(1.86)
# 3,248
Out of 5,124 analysts
362
Total ratings
31.1%
Success rate
-8.28%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $10.16 | +224.80% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.75 | +74.36% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.83 | +210.56% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.62 | +65.75% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.00 | +1,500.00% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $2.00 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $10.88 | +635.29% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $0.52 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $4.41 | +353.51% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.88 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.37 | +374.78% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.16 | +384.50% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.17 | +583.76% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $15.91 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $8.05 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.41 | +87.01% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $20.34 | +150.74% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.86 | +19.45% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.35 | +661.90% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $15.43 | +100.91% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.27 | +406.33% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.77 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $29.30 | +2,289.08% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $36.31 | -17.38% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.01 | +1,088.12% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $10.16
Upside: +224.80%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.75
Upside: +74.36%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.83
Upside: +210.56%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.62
Upside: +65.75%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.00
Upside: +1,500.00%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.00
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $10.88
Upside: +635.29%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.52
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $4.41
Upside: +353.51%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.88
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.37
Upside: +374.78%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.16
Upside: +384.50%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.17
Upside: +583.76%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $15.91
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $8.05
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $29.41
Upside: +87.01%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $20.34
Upside: +150.74%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.86
Upside: +19.45%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.35
Upside: +661.90%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $15.43
Upside: +100.91%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.27
Upside: +406.33%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.77
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $29.30
Upside: +2,289.08%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $36.31
Upside: -17.38%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.01
Upside: +1,088.12%